GIACOBELLO SCOTT M. (Chief Financial Officer) sold 10.5% of their position (2.81K shares) of WHITEHAWK THERAPEUTICS, INC. on the open market
Open‑market sale worth $6.6K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/3/2025ACC: 0001415889-25-006318
Officer· Chief Financial Officer
Since Nov 2021
-2.81K
Net shares
Net seller
$6.6K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
6.75K acquired · 9.56K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+6.75K
Price / share
—
Trade value
—
% of position
33.8%
3/1/2025
20K→26.75K
Common Stock
Direct
Shares
−2.81K
Price / share
$2.35
Trade value
$6.59K
% of position
10.5%
3/3/2025
26.75K→23.94K
Total
Net shares
+3.94K
Net value
-$6.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/1/2025 | M · Option Exercise | +6.75K | — | — | 33.8% | 20K | 26.75K |
| Common Stock Direct | 3/3/2025 | S · Sale | −2.81K | $2.35 | $6.59K | 10.5% | 26.75K | 23.94K |
| Total | +3.94K | -$6.59K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
6.75K shares
Shares
−6.75K
Strike price
Held after
20.25K
Exercisable
—
3/1/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock6.75K shares | 3/1/2025 | M · Option Exercise | −6.75K | — | 20.25K |